Market Cap: $3.33B
Filed a patent for "cd3 t-cell engagers and methods of use" on Thu, September 21, 2023
Filed a patent for "anti-coronavirus antibodies and methods of use" on Thu, May 9, 2024
Filed a patent for "anti-par-2 antibodies and methods of use thereof" on Thu, May 9, 2024
Filed a patent for "methods for determining lymphocyte receptor chain pairs" on Thu, February 9, 2023
